Efectos de un programa de estimulación cognitiva personalizada y adaptada frente a actividades de ocio estimulantes en adultos jóvenes y mayores con deterioro subjetivo o deterioro cognitivo leve. Protocolo de ensayo controlado aleatorizado
DOI:
https://doi.org/10.23938/ASSN.1118Palabras clave:
Deterioro cognitivo leve, Deterioro cognitivo subjetivo, Estimulación cognitiva computarizada, Actividades de ocio estimulantes, Atención PrimariaResumen
Fundamento. El deterioro cognitivo leve representa una etapa de transición entre el envejecimiento saludable y la demencia; el deterioro cognitivo subjetivo es un predictor clave de esta progresión. Este ensayo controlado aleatorizado tiene como objetivo comparar la eficacia de un programa personalizado de estimulación cognitiva informatizada frente a la realización actividades de ocio estimulantes en adultos jóvenes y mayores con deterioro cognitivo leve o deterioro cognitivo subjetivo.
Métodos. Se reclutaron participantes ≥50 años con deterioro cognitive leve, deterioro cognitivo subjetivo, o que obtuvieron puntuaciónes de 24-31 puntos en el Mini-Examen Cognitivo de Lobo (versión de 35 puntos). Los criterios de exclusión incluyeron vivir en una residencia, tomar inhibidores de la acetilcolinesterasa, presentar alteraciones sensoriales, agitación o haber recibido estimulación cognitiva en los últimos 12 meses. Cincuenta y nueve personas residentes en la comunidad de Zaragoza, España, fueron asignadas aleatoriamente a dos grupos de intervencion o al grupo control. El primer grupo de intervencion recibirá estimulacion cognitiva informatizada personalizada durante 30 minutos/dia, 5 dias/semana mientras el segundo grupo de intervencion participará en dos a cinco actividades de ocio estimulantes. La intervención durará ocho semanas. El grupo control recibirá la atención habitual durante el mismo periodo de tiempo. El resultado primario corresponde a la evaluación de la cognición global, mientras que los resultados secundarios comprenden mediciones de memoria, fluidez verbal, funcionamiento en actividades de la vida diaria y estado afectivo.
Descargas
Citas
NICHOLS E, STEINMETZ JD, VOLLSET SE, FUKUTAKI K, CHALEK J, ABD-ALLAH F et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. Lancet Public Healh 2022; 7(2): e105–125. https://doi.org/10.1016/S2468-2667(21)00249-8
LIANG CS, LI DJ, YANG FC, TSENG PT, CARVALHO AF, STUBBS B et al. Mortality rates in Alzheimer’s disease and non-Alzheimer’s dementias: A systematic review and meta-analysis. Lancet Healthy Longev 2021; 2(8): e479–e488. https://doi.org/10.1016/S2666-7568(21)00140-9
JACK CR, BENNETT DA, BLENNOW K, CARRILLO MC, DUNN B, HAEBERLEIN SB et al. NIA-AA research framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement 2018; 1(4): 535–562. https://doi.org/10.1016/j.jalz.2018.02.018
CHENG YW, CHEN TF, CHIU MJ. From mild cognitive impairment to subjective cognitive decline: Conceptual and methodological evolution. Neuropsychiatr Dis Treat 2017; 13: 491–498. https://doi.org/10.2147/NDT.S123428
PIKE KE, CAVUOTO MG, LI L, WRIGHT BJ, KINSELLA GJ. Subjective cognitive decline: Level of risk for future dementia and mild cognitive impairment, a meta-analysis of longitudinal studies. Neuropsychology Review2022; 32: 703–735. https://doi.org/10.1007/s11065-021-09522-3
JESSEN F, AMARIGLIO RE, BUCKLEY RF, VAN DER FLIER WM, HAN Y, MOLINUEVO JL et al. The characterisation of subjective cognitive decline. Lancet Neurol 2020; 19(3): 271–278. https://doi.org/10.1016/S1474-4422(19)30368-0
NUMBERS K, CRAWFORD JD, KOCHAN NA, DRAPER B, SACHDEV PS, BRODATY H. Participant and informant memory-specific cognitive complaints predict future decline and incident dementia: Findings from the Sydney Memory and Ageing study. PLoS One 2020; 15(5): 1–12. https://doi.org/10.1371/journal.pone.0232961
PETERSEN RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256(3): 183-194. https://doi.org/10.1111/j.1365-2796.2004.01388.x
GHANEM A, BERRY DS, BURKES A, GRILL N, HALL TM, HART KA et al. Prevalence of and annual conversion rates to mild cognitive impairment and dementia: Prospective, longitudinal study of an essential tremor cohort. Ann Neurol 2024; 95(6): 1193–1204. https://doi.org/10.1002/ana.26927
BAI W, CHEN P, CAI H, ZHANG Q, SU Z, CHEUNG T et al. Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: A meta-analysis and systematic review of epidemiology studies. Age Ageing 2022; 51(8): afac173. https://doi.org/10.1093/ageing/afac173
BRADFIELD NI. Mild Cognitive impairment: Diagnosis and subtypes. Clin EEG Neurosci 2023; 54(1): 4–11. https://doi.org/10.1177/15500594211042708
OLTRA-CUCARELLA J, FERRER-CASCALES R, ALEGRET M, GASPARINI R, DÍAZ-ORTIZ LM, RÍOS R et al. Risk of progression to Alzheimer’s disease for different neuropsychological mild cognitive impairment subtypes: A hierarchical meta-analysis of longitudinal studies. Psychol Aging 2018; 33(7): 1007-1021. https://doi.org/10.1037/pag0000294
LIAMPAS I, FOLIA V, MORFAKIDOU R, SIOKAS V, YANNAKOULIA M, SAKKA P et al. Language Differences among individuals with normal cognition, amnestic and non-amnestic MCI, and Alzheimer’s disease. Arch Clin Neuropsychol 2023; 38(4): 525–536. https://doi.org/10.1093/arclin/acac080
JUNG YH, PARK S, JANG H, CHO SH, KIM SJ, KIM JP et al. Frontal-executive dysfunction affects dementia conversion in patients with amnestic mild cognitive impairment. Sci Rep 2020; 10(1): 1–8. https://doi.org/10.1038/s41598-020-57525-6
VUJIC A, MOWSZOWSKI L, MEARES S, DUFFY S, BATCHELOR J, NAISMITH SL. Engagement in cognitively stimulating activities in individuals with Mild cognitive impairment: Relationships with neuropsychological domains and hippocampal volume. Aging, Neuropsychol Cogn 2022; 29(6): 1000–1021. https://doi.org/10.1080/13825585.2021.1955822
GONZÁLEZ-MARTÍNEZ P, OLTRA-CUCARELLA J, SITGES-MACIÁ E, BONETE-LÓPEZ B. Review and update of the criteria for objective cognitive impairment and its involvement in mild cognitive impairment and dementia. Rev Neurol 2021; 72(8): 288–295. https://doi.org/10.33588/rn.7208.2020626
American Psychiatric Association. DSM-5 Update. 2018 https://psychiatryonline.org/pb-assets/dsm/update/DSM5Update_October2018.pdf
SACHS-ERICSSON N, BLAZER DG. The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment. Aging Ment Health 2017; 19(1): 2–12. https://doi.org/10..1080/13607863.2014.920303
CHEHREHNEGAR N, NEJATI V, SHATI M, RASHEDI V, LOTFI M, ADELIRAD F et al. Early detection of cognitive disturbances in mild cognitive impairment : A systematic review of observational studies. Psychogeriatrics 2020; 20(2): 212–228. https://doi.org/10.1111/psyg.12484
JOHN A, PATEL U, RUSTED J, RICHARDS M, GAYSINA D. Affective problems and decline in cognitive state in older adults: A systematic review and meta-analysis. Psychol Med 2019; 49(3): 353–565. https://doi.org/10.1017/S0033291718001137
CHEN C, HU Z, JIANG Z, ZHOU F. Prevalence of anxiety in patients with mild cognitive impairment: A systematic review and meta-analysis. J Affect Disord 2018; 236: 211–221. https://doi.org/10.1016/j.jad.2018.04.110
DESAI R, WHITFIELD T, SAID G, JOHN A, SAUNDERS R, MARCHANT NL et al. Affective symptoms and risk of progression to mild cognitive impairment or dementia in subjective cognitive decline: A systematic review and meta-analysis. Ageing Res Rev 2021; 71: 101419. https://doi.org/10.1016/j.arr.2021.101419
LI XX, LI Z. The impact of anxiety on the progression of mild cognitive impairment to dementia in Chinese and English data bases: A systematic review and meta-analysis. Int J Geriatr Psychiatry 2018; 33(1): 131–140. https://doi.org/10.1002/gps.4694
TAN EYL, KÖHLER S, HAMEL REG, MUÑOZ-SÁNCHEZ JL, VERHEY FRJ, RAMAKERS IHGB. Depressive symptoms in mild cognitive impairment and the risk of dementia: A systematic review and comparative meta-analysis of clinical and community-based studies. J Alzheimer’s Dis 2019; 67(4): 1319–1329. https://doi.org/10.3233/JAD-180513.
KOEPSELL TD, MONSELL SE. Reversion from mild cognitive impairment to normal or near-Normal cognition; Risk factors and prognosis. Neurology 2012; 79(15): 1591–1598. https://doi.org/10.1212/WNL.0b013e31826e26b7
SHAO Z, HU M, ZHANG D, ZENG X, SHU X, WU X et al. Dose-response relationship in non-pharmacological interventions for individuals with mild cognitive impairment: A systematic review and meta-analysis of randomised controlled trials. J Clin Nurs 2022; 31(23–24): 3390-3401. https://doi.org/10.1111/jocn.16240
LOWRANI M, INDARWATI R, LESTARI P. Non-pharmacological therapy for the elderly to prevent dementia through cognitive stimulation therapy: A systematic review. J Ners 2020; 15(2 Special Issue): 221–229. https://doi.org/10.20473/jn.v15i2.19018
LESHER DAM, MULCAHEY MJ, HERSHEY P, STANTON DB, TIEDGEN AC. Alignment of outcome instruments used in hand therapy with the Occupational Therapy Practice Framework: Domain and process and the International Classification of Functioning, Disability and Health: A scoping review. Am J Occup Ther 2017; 71(1): 7101190060p1-p12. https://doi.org/10.5014/ajot.2017.016741
DONNELLY CA, BRENCHLEY CL, CRAWFORD CN, LETTS LJ. The emerging role of occupational therapy in primary care. Can J Occup Ther 2014; 81(1): 51–61. https://doi.org/10.1177/0008417414520683
College of Occupational Therapists. Reducing the pressure on hospitals: A report on the value of occupational therapy in Scotland. London: College of Occupational Therapists Limited, 2016.
Salmon N. Cognitive stimulation therapy versus acetyl cholinesterase inhibitors for mild to moderate dementia: A latter-day David and Goliath? Br J Occup Ther 2006; 69(11): 528–530. https://doi.org/10.1177/030802260606901107
WOODS B, RAI HK, ELLIOTT E, AGUIRRE E, ORRELL M, SPECTOR A. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev 2023; 2023(1): CD005562. https://doi.org/10.1002/14651858.CD005562.pub3
WANG Y QUAN, JIA R XIA, LIANG J HONG, LI J, QIAN S, LI J YU et al. Effects of non-pharmacological therapies for people with mild cognitive impairment. A Bayesian network meta-analysis. Int J Geriatr Psychiatry 2020; 35(6): 591–600. https://doi.org/10.1002/gps.5289.
AGUIRRE E, SPECTOR A, HOE J, RUSSELL IT, KNAPP M, WOODS RT et al. Maintenance cognitive stimulation therapy (CST) for dementia: A single-blind, multi-centre, randomized controlled trial of maintenance CST vs. CST for dementia. Trials 2010; 11: 46. https://doi.org/10.1186/1745-6215-11-46
EAGLESTONE G, GKAINTATZI E, JIANG H, STONER C, PACELLA R, MCCRONE P. Cost-effectiveness of non-pharmacological interventions for mild cognitive impairment and dementia: A systematic review of economic evaluations and a review of reviews. PharmacoEconomics - Open 2023; 7(6): 887–914. https://doi.org/10.1007/s41669-023-00440-z
HALLAM B, REES J, PETERSEN I, COOPER C, AVGERINOU C, WALTERS K. How are people with mild cognitive impairment or subjective memory complaints managed in primary care? A systematic review. Fam Pract 2021; 38(5): 669–683. https://doi.org/ 10.1093/fampra/cmab014
WANG HX, KARP A, WINBLAD B, FRATIGLIONI L. Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: A Longitudinal Study from the Kungsholmen Project. Am J Epidemiol 2022; 155(12): 1081-1087. https://doi.org/10.1093/aje/155.12.1081
AUGHTERSON H. Social prescribing for mental health and well-being: mechanisms of action, active ingredients, and barriers & enablers to effective engagement. Thesis for examination for PhD. Department of behavioural Science & Health, University College London, June 2022. https://discovery.ucl.ac.uk/id/eprint/10154892/2/Aughterson_10154892_thesis_redacted_article_pdf.pdf
HOWARTH M, GRIFFITHS A, SILVA A, GREEN R. Social prescribing : A ‘ natural ’ community-based solution. Br J Comm Nurs 2016 ; 25(6): 294-298. https://doi.org/10.12968/bjcn.2020.25.6.294
MAHUT M, FORTUNE D. Social prescribing and therapeutic recreation: Making the connection. Ther Recreation J 2021; 55(2): 135–149. https://doi.org/10.18666/TRJ-2021-V55-I2-10694
JONES M, KIMBERLEE R, DEAVE T, EVANS S. The role of community centre-based arts, leisure and social activities in promoting adult well-being and healthy lifestyles. Int J Environ Res Public Health 2013; 10(5): 1948–1962. https://doi.org/10.3390/ijerph10051948
ROTENBERG S, LEUNG C, QUACH H, ANDERSON ND, DAWSON DR. Occupational performance issues in older adults with subjective cognitive decline. Disabil Rehabil 2022; 44(17): 4681–4688. https://doi.org/10.1080/09638288.2021.1916626.
FALLAHPOUR M, BORELL L, LUBORSKY M, NYGÅRD L. Leisure-activity participation to prevent later-life cognitive decline: A systematic review. Scand J Occup Ther 2015; 23(3): 162–197. https://doi.org/10.3109/11038128.2015.1102320
GÓMEZ-SORIA I, PERALTA-MARRUPE P, PLO F. Cognitive stimulation program in mild cognitive impairment A randomized controlled trial. Dement Neuropsychol. 2020; 14(2): 110–117. https://doi.org/10.1590/1980-57642020dn14-02000
GÓMEZ-SORIA I, BRANDÍN-DE LA CRUZ N, CUENCA ZALDÍVAR JN, CALVO S, HERRERO P, CALATAYUD E. Effectiveness of personalized cognitive stimulation in older adults with mild possible cognitive impairment: A 12-month follow-up cognitive stimulation in mild cognitive impairment. Clin Gerontol 2022; 45(4): 878-890. https://doi.org/10.1080/07317115.2021.1937764
GÓMEZ-SORIA I, ANDRÉS ESTEBAN EM, GÓMEZ BRUTON A, PERALTA-MARRUPE P. Long-term effect analysis of a cognitive stimulation program in mild cognitive impairment elderly in Primary Care: A randomized controlled trial. Aten Primaria 2021; 53(7): 102053. https://doi.org/10.1016/j.aprim.2021.102053
GÓMEZ-SORIA I, FERREIRA C, OLIVÁN-BLÁZQUEZ B, AGUILAR-LATORRE A, CALATAYUD E. Effects of cognitive stimulation program on cognition and mood in older adults, stratified by cognitive levels: A randomized controlled trial. Arch Gerontol Geriatr 2023; 110(3): 104984. https://doi.org/10.1016/j.archger.2023.104984
CALATAYUD E, SUBIRON-VALERA AB, MARCÉN-ROMÁN Y, SALAVERA C, ANDRADE-GÓMEZ E, RODRÍGUEZ-ROCA B et al. Effects on language and verbal fluency of a cognitive stimulation program in older adults: Randomized controlled trial. Sustain 2023; 15(3): 2533. https://doi.org/10.3390/su15032533
DJABELKHIR L, WU YH, VIDAL JS, CRISTANCHO-LACROIX V, MARLATS F, LENOIR H et al. Computerized cognitive stimulation and engagement programs in older adults with mild cognitive impairment: Comparing feasibility, acceptability, and cognitive and psychosocial effects. Clin Interv Aging 2017; 12: 1967–1975. https://doi.org/10.2147/CIA.S145769
DJABELKHIR-JEMMI L, WU YH, BOUBAYA M, MARLATS F, LEWIS M, VIDAL JS et al. Differential effects of a computerized cognitive stimulation program on older adults with mild cognitive impairment according to the severity of white matter hyperintensities. Clin Interv Aging 2018; 13: 1543-1544. https://doi.org/10.2147/CIA.S152225
OLIVEIRA J, GAMITO P, SOUTO T, CONDE R, FERREIRA M, COROTNEAN T et al. Virtual reality-based cognitive stimulation on people with mild to moderate dementia due to alzheimer’s disease: A pilot randomized controlled trial. Int J Environ Res Public Health 2021; 18(10): 5290. https://doi.org/10.3390/ijerph18105290
TARNANAS I, TSOLAKIS A, TSOLAKI M. Assessing virtual reality environments as cognitive stimulation method for patients with MCI. Studies in Computational Intelligence 2014; 536: 39–74. https://doi.org/10.1007/978-3-642-45432-5_4.
DOI T, VERGHESE J, MAKIZAKO H, TSUTSUMIMOTO K, HOTTA R, NAKAKUBO S et al. Effects of cognitive leisure activity on cognition in mild cognitive impairment: Results of a randomized controlled trial. J Am Med Dir Asso 2017; 18(8): 686–691. https://,doi.org/10.1016/j.jamda.2017.02.013
TESKY VA, KÖBE T, WITTE AV, FLÖEL A, SCHUCHARDT JP, HHAHN A et al. Feasibility and first results of a group program to increase the frequency of cognitively stimulating leisure activities in people with mild cognitive impairment (AKTIVA-MCI). Clin Interv Aging 2017; 12: 1459–1469. https://,doi.org/10.2147/CIA.S139146
WILSON RS, DE MENDES LEON CF, BARNES LL. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 2002; 287(6): 742-748. https://,doi.org/10.1001/jama.287.6.742
Ayuntamiento de Zaragoza. Observatorio. Cifras de Zaragoza. Datos demográficos del padrón municipal de habitantes a fecha de 01-01-2024. Consultado el 16 de marzo de 2025. https://www.zaragoza.es/contenidos/estadistica/Cifras-24.pdf
Calero MD, Navarro E, Robles P, García TM. Validez del Mini Examen Cognitivo de Lobo et al en la detección del deterioro cognitivo asociado a demencias. Neurología 2000; 15(8): 337–342.
VALLESI A. Age differences in sustained attention tasks : A meta-analysis. Psychon Bull Rev 2021; 28(6): 1755–1775. https://,doi.org/10.3758/s13423-021-01908-x
LEVINOFF EJ, SAUMIER D, & CHERTKOW H. Focused attention de W cits in patients with Alzheimer's disease and mild cognitive impairment. Brain Cogn 2005; 57(2): 127–130. https://,doi.org/10.1016/j.bandc.2004.08.058
LEROI I, VATTER S, CARTER LA, SMITH SJ, ORGETA V, POLIAKOFF E ET al. Parkinson’s-adapted cognitive stimulation therapy: A pilot randomized controlled clinical trial. Ther Adv Neurol Disord 2019; 12: 1756286419852217. https://doi.org/10.1177/1756286419852217
KARP A, PAILLARD-BORG S, WANG HX, SILVERSTEIN M, WINBLAD B, FRATIGLIONI L. Mental, physical and social components in leisure activities equally contribute to decrease dementia risk. Dement Geriatr Cogn Disord 2006; 21(2): 65–73. https://doi.org/10.1159/000089919
Ministerio de Trabajo y Asuntos Sociales. Clasificación internacional del funcionamiento, de la discapacidad y de la salud. Madrid: CIF, 2004.
BOOP C, CAHILL SM, DAVIS C, DORSEY J, GIBBS V, HERR B et al. Occupational therapy practice framework: Domain and process fourth edition. Am J Occup Ther 2020; 74(Suppl 2): 7412410010p1-7412410010p87. https://doi.org/10.5014/ajot.2020.74S2001
KIELHOFNER G. Modelo de ocupación humana: teoría y aplicación. 4a ed. Buenos Aires: Médica Panamericana, 2011: 61-62.
DE LAS HERAS C. Modelo de ocupación humana. Madrid: Síntesis, 2015.
LEE SW, KIELHOFNER G, MORLEY M, HEASMAN D, GARNHAM M, WILLIS S et al. Impact of using the Model of Human Occupation: A survey of occupational therapy mental health practitioners’ perceptions. Scand J Occup Ther 2012; 19(5): 450–456. https://doi.org/10.3109/11038128.2011.645553
GÓMEZ TOLÓN J. Fundamentos Metodológicos de la Terapia Ocupacional. 1a ed. Zaragoza: Mira, 1997.
World Health Organization. Guidance for best practices for clinical trials. 2024. https://www.hra.nhs.uk/about-us/news-updates/world-health-organization-guidance-best-practices-clinical-trials/
MITCHELL AJ. The Mini-Mental State Examination (MMSE): An update on its diagnostic validity for cognitive disorders. In: Larner AJ (editor). Cognitive screening instruments: A practical approach. London: Springer, 2013: 15–46.
LOBO A. Revalidacion y normalizacion del mini-examen cognoscitivo (primera version en castellano del Mini-Mental Status Examination) en la poblacion general geriatrica. Med Clin (Barc) 1999; 112 (20): 767-774. Erratum: Med Clin (Barc) 1999; 113(5): 197.
LAZAROU I, MORAITOU D, PAPATHEODOROU M, VAVOURAS I, LOKANTIDOU C, AGOGIATOU C et al. Adaptation and validation of the Memory Alteration Test (M@T) in Greek Middle-aged, older, and older-old population with subjective cognitive decline and mild cognitive impairment. J Alzheimer’s Dis 2021; 84(3): 1219–1232. https://doi.org/10.3233/JAD-210558
RAMI L, BOSCH B, VALLS-PEDRET C, CAPRILE C, SÁNCHEZ-VALLE DÍAZ R, MOLINUEVO JL. Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer’s disease. Rev Neurol 2009; 49(4): 169–174.
AMIEVA H, LETENNEUR L, DARTIGUES JF, ROUCH-LEROYER I, SOURGEN C, D’ALCHÉE-BIRÉE F et al. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord 2004; 18(1): 87–93. https://doi.org/10.1159/000077815.
PASCUAL MILLÁN LF, MARTÍNEZ QUIÑONES JV, MODREGO PARDO P, MOSTACERO MIGUEL E, LÓPEZ DEL VAL J, MORALES ASÍN F. The set-test for diagnosis of dementia. Neurologia 1990; 5(3): 82–85.
MUÑOZ-NEIRA C, LÓPEZ OL, RIVEROS R, NÚÑEZ-HUASAF J, FLORES P, SLACHEVSKY A. The Technology - Activities of daily Living questionnaire: A version with a technology-related subscale. Dement Geriatr Cogn Disord 2012; 33(6): 361–371. https://doi.org/10.1159/000338606
CUSTODIO N, LIRA D, HERRERA-PEREZ E, NUÑEZ DEL PRADO L, PARODI J, GUEVARA-SILVA E et al. The Memory Alteration Test discriminates between cognitively healthy status, mild cognitive impairment and Alzheimer’s Disease. Dement Geriatr Cogn Dis Extra 2014; 4(2): 314–321. https://doi.org/10.1159/000365280
PFEFFER RI, KUROSAKI TT, HARRAH CH, CHANCE JM, FILOS S. Measurement of functional activities in older adults in the community. J Gerontol 1982; 37(3): 323–329. https://doi.org/10.1093/geronj/37.3.323
BEREZUK C, SCOTT SC, BLACK SE, ZAKZANIS KK. Cognitive reserve, cognition, and real-world functioning in MCI: A systematic review and meta-analysis. J Clin Exp Neuropsychol 2021; 43(10): 991–1005. https://doi.org/10.1080/13803395.2022.2047160
GUERIN JM, COPERSINO ML, SCHRETLEN DJ. Clinical utility of the 15-item geriatric depression scale (GDS-15) for use with young and middle-aged adults. J Affect Disord 2018; 241: 59–62. https://doi.org/10.1016/j.jad.2018.07.038
MARC LG, RAUE PJ, BRUCE ML. Screening performance of the 15-item geriatric depression scale in a diverse elderly home care population. Am J Geriatr Psychiatry 2008; 16(11): 914–921. https://doi.org/10.1097/JGP.0b013e318186bd67
JUSTO-HENRIQUES SI, PÉREZ-SÁEZ E, CARVALHO JO, BOBROWICZ-CAMPOS E, APÓSTOLO JLA, OTERO P et al. Reliability and validity of the Geriatric Depression Scale in a sample of Portuguese older adults with mild-to-moderate cognitive impairment. Brain Sci 2023; 13(8): 1160. https://doi.org/10.3390/brainsci13081160
GOLDBERG D, BRIDGES K, DUNCAN-JONES P, GRAYSON D. Detecting anxiety and depression in general medical settings. Br Med J 1988; 297(6653): 897–899. https://doi.org/10.1136/bmj.297.6653.897
ZUO X, TANG Y, CHEN Y ZZ. Effects of electronic serious games on older adults with Alzheimer’s disease and mild cognitive impairment: Systematic review with Meta-analysis of randomized controlled trials. JMIR Serious Games 2024; 12: e55785. https://doi.org/10.2196/55785
COHEN JW. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates, 1988.
World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA 2013; 310(20): 2191-2194. https://doi.org/10.1001/jama.2013.281053
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-CompartirIgual 4.0.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
